CVE-2022-45611
N/A
N/A
Summary
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Affected Software
| Vendor | Product | Version Range | Status |
|---|---|---|---|
| n/a | n/a | n/a | affected |
Weaknesses
- n/a
ADP Enrichment
CVE Program Container
Additional References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
CISA ADP Vulnrichment
- SSVC:
- Exploitation: none
- Automatable: yes
- Technical Impact: total
References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
Feedback
Was this page helpful?
Glad to hear it! Please tell us how we can improve.
Sorry to hear that. Please tell us how we can improve.